Pfizer’s Q3 Profit Tumbles on Lipitor Patent Expiration; Guidance Lowered; New $10 Billion Buyback Program Announced (PFE)

By
A A A
Share |

Drug maker Pfizer Inc. ( PFE ) on Thursday posted in-line third quarter profits, although its revenue missed expectations, and unveiled plans for a massive new $10 billion share buyback program.

The New York-based company reported third quarter net income of $3.21 billion, or 43 cents per share, compared with $3.74 billion, or 48 cents per share, in the year-ago period. Excluding special items, adjusted profit was 53 cents per share.

Revenue plunged 16% from last year to $14 billion.

On average, Wall Street analysts expected a matching profit of 53 cents per share, albeit on higher revenue of $14.64 billion.

Looking ahead, PFE lowered its full-year 2012 earnings forecast. The company now expects 2012 earnings of $2.14 to $2.17 per share, down from $2.14 to $2.22 previously.

In another announcement, Pfizer's board of directors approved plans for a massive new $10 billion share buyback program. The new program is in addition its its current repurchase plan, which currently has about $4.1 billion remaining.

Pfizer shares fell 41 cents, or -1.7%, in premarket trading Thursday.

Pfizer Inc. ( PFE ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: PFE

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

92%

Most Active by Volume

55,414,702
  • $15.38 ▼ 0.39%
38,503,210
  • $66.34 ▲ 2.26%
36,466,704
  • $8.36 ▼ 9.52%
35,253,294
  • $26.55 ▲ 1.34%
32,752,347
  • $6.55 ▲ 1.87%
31,778,001
  • $95.22 ▲ 0.19%
28,396,556
  • $51.49 ▼ 0.62%
23,800,987
  • $42.09 ▲ 0.97%
As of 7/11/2014, 04:03 PM